Neurocrine Biosciences Inc (NASDAQ:NBIX)

79.86
Delayed Data
As of Apr 18
 +2.99 / +3.89%
Today’s Change
41.76
Today|||52-Week Range
92.98
+2.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-60.5M-88.9M-141.1M-142.5M
 
 
 
 
 
Depreciation827.0K1.0M1.5M2.4M
 
 
 
 
 
Total Other Cash Flow11.0M41.2M27.7M54.6M
 
 
 
 
 
Funds From Operations-48.8M-46.7M-112.0M-85.5M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.6M-8.7M-5.8M8.8M
 
 
 
 
 
Net Cash Flow - Operating Activities-47.1M-38.0M-106.2M-94.3M
 
 
 
 
 
 
InvestingIncrease In Investments-257.5M-449.1M-298.9M-583.4M
 
 
 
 
 
Decrease In Investments154.1M255.1M415.8M339.1M
 
 
 
 
 
Capital Expenditures-1.6M-1.9M-4.1M-6.9M
 
 
 
 
 
Fixed Asset Disposal45.0K9.0K13.0K7.0K
 
 
 
 
 
Other Investing - Uses-388.0K0.000.00--
 
 
Other Investing - Sources--0.000.00383.0K
 
 
Net Cash Flow Investing-105.4M-195.9M112.9M-250.9M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.00502.8M
 
 
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale138.7M277.0M2.4M13.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing138.7M277.0M2.4M516.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash-13.8M43.1M9.1M171.4M